Birchbrook’s Boston Scientific BSX Stock Holding History

Birchbrook’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.8K	Hold	110	–	–	﹤0.01%	227
2026 Q2	$4.7K	Sell	110 -100	-48%	-$5.43K	﹤0.01%	238
2026 Q1	$13.2K	Hold	210	–	–	0.01%	184
2025 Q4	$20K	Buy	210 +50	+31%	+$4.9K	0.01%	175
2025 Q3	$15.6K	Hold	160	–	–	0.01%	173
2025 Q2	$17.2K	Buy	160 +100	+167%	+$10.1K	0.01%	169
2025 Q1	$6.05K	Hold	60	–	–	﹤0.01%	204
2024 Q4	$5.36K	Hold	60	–	–	﹤0.01%	227
2024 Q3	$5.03K	Hold	60	–	–	﹤0.01%	214
2024 Q2	$4.62K	Hold	60	–	–	﹤0.01%	217
2024 Q1	$4.11K	Hold	60	–	–	﹤0.01%	227
2023 Q4	$3.47K	Buy	+60	New	+$3.2K	﹤0.01%	254

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Birchbrook's BSX Position: Q3 2026 in Review

Birchbrook held its Boston Scientific (BSX) position steady in Q3 2026 at 110 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #227.

Birchbrook first reported a position in BSX in Q4 2023 and has held it in 12 quarters since. The position peaked at $20K in Q4 2025. 515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Birchbrook held 110 shares of Boston Scientific worth $4.8K as of Q3 2026.
Birchbrook left its Boston Scientific share count unchanged in Q3 2026.
Boston Scientific made up ﹤0.01% of Birchbrook's portfolio in Q3 2026, its #227 holding.
Birchbrook first reported a position in Boston Scientific in Q4 2023 and has held it in 12 quarters since.
Birchbrook's Boston Scientific position peaked at $20K in Q4 2025.
515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.